-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
Dihydromyricetin
Category | Influenza Virus |
CAS | 27200-12-0 |
Description | Ampelopsin is a flavanonol isolated from the herb of Myrica rubra (Lour.)Zucc., exhibiting antioxidant, antiproliferative, anti-apoptotic, and anti-alcohol intoxication properties. Ampelopsin is a natural compound used in cosmetics material. It can improve the skin barrier and has multiple effects such as anti-aging and removing wrinkles, whitening and lightening spots, soothing repair, anti-inflammatory, and antibacterial. In addition, it has the effect of healing wounds and nursing hair. |
Product Information
Synonyms | Ampelopsis Grossedentata Extract; Water-Soluble Dihydromyricetin; (2R,3R)-2,3-Dihydro-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-1-benzopyran-4-one; 4H-1-Benzopyran-4-one, 2,3-dihydro-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-, (2R-trans)-; Ampelopsin; Flavanone, 3,3',4',5,5',7-hexahydroxy-; (+)-Ampelopsin; (+)-Dihydromyricetin; Ampelopsin (flavanol); Ampeloptin; REL-Eqyms 98 |
IUPAC Name | (2R,3R)-3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-2,3-dihydrochromen-4-one |
Molecular Weight | 320.25 |
Molecular Formula | C15H12O8 |
Canonical SMILES | C1=C(C=C(C(=C1O)O)O)C2C(C(=O)C3=C(C=C(C=C3O2)O)O)O |
InChI | InChI=1S/C15H12O8/c16-6-3-7(17)11-10(4-6)23-15(14(22)13(11)21)5-1-8(18)12(20)9(19)2-5/h1-4,14-20,22H/t14-,15+/m0/s1 |
InChIKey | KJXSIXMJHKAJOD-LSDHHAIUSA-N |
Boiling Point | 780.7±60.0°C at 760 Torr |
Melting Point | 239-241°C |
Flash Point | 296.7±26.4 °C |
Purity | 95% |
Density | 1.808±0.06 g/cm3 |
Solubility | Soluble in Acetone (Freely), DMSO, Ethanol, Ethyl Acetate (Very Slightly), hot Ethanol (Freely), hot Water (Freely), Methanol |
Appearance | Off-white to pale yellow powder |
Application | Food, Health Care Products |
Storage | Dark, cool and dry place. |
Animal Admin | Totally 40 male Sprague-Dawley (SD) rats are used. The rats are randomly divided into four groups including normal control group, D-gal model group, and D-gal combined with DHM at the doses of 100 and 200 mg/kg-d groups with 10 rats in each group. After adapting to new environment for 1 week, the rats from DHM groups are administered with DHM dissolved in distilled water at the designated dosages by gavage once a day at 8:00am for 6 consecutive weeks. Except from the normal control group, the rats from other groups are subjected to subcutaneous injection of D-gal at the dose of 150 mg/kg.d for 6 consecutive weeks. Each administration of DHM should be 2 h ahead of D-gal injection. |
Complexity | 445 |
Exact Mass | 320.05321734 |
Index Of Refraction | 1.798 |
In Vitro | Dihydromyricetin, a flavonol, significantly inhibits the catalytic activities of dihydropyrimidinase toward both the natural substrate dihydrouracil and xenobiotic substrate 5-propyl-hydantoin. Dihydromyricetin exhibits a significant inhibitory effect on the activities of dihydropyrimidinase for both substrates, even more than Myricetin does. The IC50 values of Dihydromyricetin for dihydropyrimidinase determined from the titration curves using Dihydrouracil and 5-propyl-hydantoin are 48±2 and 40±2 μM, respectively. Dihydromyricetin can activate Autophagy through inhibiting mTOR signaling. |
In Vivo | Changes in learning and memory capacity in rats administrated normal control group, D-gal group, D-gal+Dihydromyricetin (100 mg/kg) group, D-gal+Dihydromyricetin (200 mg/kg) group assessed by morris water maze (MWM) (n=10 per group). Dihydromyricetin (DHM) treatment significantly shortens the escape latency when compared with D-gal-induced model group. |
PSA | 147.68000 |
Target | Dihydropyrimidinase:48 μM (IC50) mTORC1 mTORC2 Autophagy |
Vapor Pressure | 0.0±2.8 mmHg at 25°C |
XLogP3-AA | 1.1 |